US 10472629
Methods and compositions for modlating apolipoprotein (A) expression
granted A61PA61P29/00A61P3/00
Quick answer
US patent 10472629 (Methods and compositions for modlating apolipoprotein (A) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P29/00, A61P3/00, A61P9/00, A61P9/10